StockData
Stemtech Corp logo

Stemtech Corp (STEK) stock

STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $296.22KP/E –Yield –

Stemtech gross margin

Gross margin is gross profit as a percentage of revenue.

Stemtech's gross margin for the twelve months ending Sep 30, 2026 was 75.7%. For fiscal 2025 it was 80.3%, against 73.8% the year before. The highest annual figure on record is 80.3% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202580.3%+6.5
FY2024Dec 31, 202473.8%−5.9
FY2023Dec 31, 202379.6%+5.2
FY2022Dec 31, 202274.5%−1.9
FY2021Dec 31, 202176.3%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ3 2026Sep 30, 202675.6%−4.5
Q2 FY2026CQ2 2026Jun 30, 202674.0%−5.1
Q1 FY2026CQ1 2026Mar 31, 202676.4%−6.6
Q4 FY2025CQ4 2025Dec 31, 202577.4%−2.1
Q3 FY2025CQ3 2025Sep 30, 202580.1%+16.9
Q2 FY2025CQ2 2025Jun 30, 202579.1%+4.1
Q1 FY2025CQ1 2025Mar 31, 202583.0%+8.0
Q4 FY2024CQ4 2024Dec 31, 202479.6%−4.3
Q3 FY2024CQ3 2024Sep 30, 202463.1%−14.4
Q2 FY2024CQ2 2024Jun 30, 202474.9%−3.2
Q1 FY2024CQ1 2024Mar 31, 202475.0%−3.4
Q4 FY2023CQ4 2023Dec 31, 202383.9%+14.2
Q3 FY2023CQ3 2023Sep 30, 202377.6%−5.2
Q2 FY2023CQ2 2023Jun 30, 202378.2%+9.0
Q1 FY2023CQ1 2023Mar 31, 202378.4%+1.1
Q4 FY2022CQ4 2022Dec 31, 202269.7%−13.6
Q3 FY2022CQ3 2022Sep 30, 202282.8%–
Q2 FY2022CQ2 2022Jun 30, 202269.2%–
Q1 FY2022CQ1 2022Mar 31, 202277.3%–
Q1 FY2021CQ1 2021Mar 31, 202183.3%–

More Stemtech figures

See a number that looks wrong?